These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23552901)

  • 21. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Implications of Diastolic Dysfunction Change in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Kim EK; Hahn JY; Park TK; Lee JM; Song YB; Chang SA; Park SJ; Choi SH; Lee SC; Gwon HC; Oh JK; Park SW
    Circ J; 2019 Aug; 83(9):1891-1900. PubMed ID: 31292309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.
    Gong X; Zhou L; Ding X; Chen H; Li H
    BMC Cardiovasc Disord; 2021 Apr; 21(1):182. PubMed ID: 33858349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent characteristics and outcomes of Japanese stable angina pectoris after percutaneous coronary intervention. An observational cohort study using the Shinken Database.
    Kaneko H; Yajima J; Oikawa Y; Tanaka S; Fukamachi D; Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    Int Heart J; 2013; 54(6):335-40. PubMed ID: 24309441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the relation between IVUS measurements and clinical outcome in elderly patients after sirolimus-eluting stent implantation for de novo coronary lesions.
    Du R; Zhang RY; Zhang Q; Shi YH; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1653-62. PubMed ID: 22222382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Aged Patients With Unprotected Left Main Artery Lesions.
    Wei Z; Xie J; Wang K; Kang L; Dai Q; Bai J; Xu B
    Int Heart J; 2016 Dec; 57(6):682-688. PubMed ID: 27829638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
    Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
    BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
    Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention.
    Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y
    BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
    Kunadian V; Pugh A; Zaman AG; Qiu W
    Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of revascularization strategy in patients with acute myocardial infarction and renal insufficiency with multivessel disease.
    Park H; Hong YJ; Rhew SH; Kim SS; Jeong YW; Jeong HC; Cho JY; Jang SY; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC
    Korean J Intern Med; 2015 Mar; 30(2):177-90. PubMed ID: 25750559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the predictive value of EuroSCORE, SYNTAX score, and clinical SYNTAX score for outcomes of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease.
    Jou YL; Lu TM; Chen YH; Sung SH; Wang KL; Huang SS; Lin WT; Chan WL; Lin SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):222-30. PubMed ID: 22334399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality.
    Goto T; Wakami K; Fukuta H; Fujita H; Tani T; Ohte N
    Heart Vessels; 2016 May; 31(5):734-43. PubMed ID: 25771802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.